@inproceedings{chakraborty-2024-rgat,
title = "{RGAT} at {S}em{E}val-2024 Task 2: Biomedical Natural Language Inference using Graph Attention Network",
author = "Chakraborty, Abir",
editor = {Ojha, Atul Kr. and
Do{\u{g}}ru{\"o}z, A. Seza and
Tayyar Madabushi, Harish and
Da San Martino, Giovanni and
Rosenthal, Sara and
Ros{\'a}, Aiala},
booktitle = "Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)",
month = jun,
year = "2024",
address = "Mexico City, Mexico",
publisher = "Association for Computational Linguistics",
url = "https://aclanthology.org/2024.semeval-1.19",
doi = "10.18653/v1/2024.semeval-1.19",
pages = "116--122",
abstract = "In this work, we (team RGAT) describe our approaches for the SemEval 2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials (NLI4CT). The objective of this task is multi-evidence natural language inference based on different sections of clinical trial reports. We have explored various approaches, (a) dependency tree of the input query as additional features in a Graph Attention Network (GAT) along with the token and parts-of-speech features, (b) sequence-to-sequence approach using various models and synthetic data and finally, (c) in-context learning using large language models (LLMs) like GPT-4. Amongs these three approaches the best result is obtained from the LLM with 0.76 F1-score (the highest being 0.78), 0.86 in faithfulness and 0.74 in consistence.",
}
<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3">
<mods ID="chakraborty-2024-rgat">
<titleInfo>
<title>RGAT at SemEval-2024 Task 2: Biomedical Natural Language Inference using Graph Attention Network</title>
</titleInfo>
<name type="personal">
<namePart type="given">Abir</namePart>
<namePart type="family">Chakraborty</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<originInfo>
<dateIssued>2024-06</dateIssued>
</originInfo>
<typeOfResource>text</typeOfResource>
<relatedItem type="host">
<titleInfo>
<title>Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)</title>
</titleInfo>
<name type="personal">
<namePart type="given">Atul</namePart>
<namePart type="given">Kr.</namePart>
<namePart type="family">Ojha</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="given">Seza</namePart>
<namePart type="family">Doğruöz</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Harish</namePart>
<namePart type="family">Tayyar Madabushi</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Giovanni</namePart>
<namePart type="family">Da San Martino</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sara</namePart>
<namePart type="family">Rosenthal</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Aiala</namePart>
<namePart type="family">Rosá</namePart>
<role>
<roleTerm authority="marcrelator" type="text">editor</roleTerm>
</role>
</name>
<originInfo>
<publisher>Association for Computational Linguistics</publisher>
<place>
<placeTerm type="text">Mexico City, Mexico</placeTerm>
</place>
</originInfo>
<genre authority="marcgt">conference publication</genre>
</relatedItem>
<abstract>In this work, we (team RGAT) describe our approaches for the SemEval 2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials (NLI4CT). The objective of this task is multi-evidence natural language inference based on different sections of clinical trial reports. We have explored various approaches, (a) dependency tree of the input query as additional features in a Graph Attention Network (GAT) along with the token and parts-of-speech features, (b) sequence-to-sequence approach using various models and synthetic data and finally, (c) in-context learning using large language models (LLMs) like GPT-4. Amongs these three approaches the best result is obtained from the LLM with 0.76 F1-score (the highest being 0.78), 0.86 in faithfulness and 0.74 in consistence.</abstract>
<identifier type="citekey">chakraborty-2024-rgat</identifier>
<identifier type="doi">10.18653/v1/2024.semeval-1.19</identifier>
<location>
<url>https://aclanthology.org/2024.semeval-1.19</url>
</location>
<part>
<date>2024-06</date>
<extent unit="page">
<start>116</start>
<end>122</end>
</extent>
</part>
</mods>
</modsCollection>
%0 Conference Proceedings
%T RGAT at SemEval-2024 Task 2: Biomedical Natural Language Inference using Graph Attention Network
%A Chakraborty, Abir
%Y Ojha, Atul Kr.
%Y Doğruöz, A. Seza
%Y Tayyar Madabushi, Harish
%Y Da San Martino, Giovanni
%Y Rosenthal, Sara
%Y Rosá, Aiala
%S Proceedings of the 18th International Workshop on Semantic Evaluation (SemEval-2024)
%D 2024
%8 June
%I Association for Computational Linguistics
%C Mexico City, Mexico
%F chakraborty-2024-rgat
%X In this work, we (team RGAT) describe our approaches for the SemEval 2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials (NLI4CT). The objective of this task is multi-evidence natural language inference based on different sections of clinical trial reports. We have explored various approaches, (a) dependency tree of the input query as additional features in a Graph Attention Network (GAT) along with the token and parts-of-speech features, (b) sequence-to-sequence approach using various models and synthetic data and finally, (c) in-context learning using large language models (LLMs) like GPT-4. Amongs these three approaches the best result is obtained from the LLM with 0.76 F1-score (the highest being 0.78), 0.86 in faithfulness and 0.74 in consistence.
%R 10.18653/v1/2024.semeval-1.19
%U https://aclanthology.org/2024.semeval-1.19
%U https://doi.org/10.18653/v1/2024.semeval-1.19
%P 116-122
Markdown (Informal)
[RGAT at SemEval-2024 Task 2: Biomedical Natural Language Inference using Graph Attention Network](https://aclanthology.org/2024.semeval-1.19) (Chakraborty, SemEval 2024)
ACL